No products in the cart.
Contaminated drinking water is associated with increased risk of uterine cancer
1. In a large cohort study, an increased risk of uterine cancer was found in women with enrollment addresses linked ...
Tag: gynecologic oncology
Delayed CIN2 treatment does not increase cancer risk
1. In this target trial emulation, delayed treatment of cervical intraepithelial neoplasia grade 2 (CIN 2) was associated with a ...
The quadrivalent human papillomavirus vaccine provides effective and durable protection against invasive cervical cancer
1. In this cohort study, the quadrivalent human papillomavirus (HPV) vaccine provides strong, long-lasting protection against invasive cervical cancer, with ...
2 Minute Medicine Rewind March 2, 2026
Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based study 1. In this cohort study, ...
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia
1. Glucagon-like peptide-1 receptor agonists (GLP-1RA) in combination with progestins are significantly more effective at reducing endometrial cancer (EC) risk ...
Early menarche and later menopause are associated with increased ovarian cancer risk
1. Across the premenopausal and postmenopausal groups, early menarche, later menopause, and longer reproductive span were associated with higher ovarian ...
2 Minute Medicine Rewind February 9, 2026
Reproductive Shifts and Ovarian Cancer Risk in Women Aged 40 Years or Older 1. Across the premenopausal and postmenopausal groups, ...
An ultrasound test may more reliably detect ovarian cancer in premenopausal women than the Risk of Malignancy Index
1. This cohort study found that the IOTA ADNEX ultrasound model at a 10% risk threshold detected more ovarian cancers ...
Patients who do not undergo hysterectomy for low-grade endometrial cancer may be at higher risk of death
1. In this cohort study, patients with early-stage, low-grade endometrial cancer who did not undergo hysterectomy, specifically those from racial ...
Relacorilant plus nab-paclitaxel improves survival in platinum-resistant ovarian cancer patients
1. Progression-free and overall survival were greater in relacorilant plus nab-paclitaxel compared to nab-paclitaxel alone. 2. The rate of adverse ...
